Multi-Omics Approaches to Define Calcific Aortic Valve Disease Pathogenesis.
Blaser MC, Kraler S, Lüscher TF, Aikawa E.
Circ Res. 2021 Apr 30;128(9):1371-1397. doi: 10.1161/CIRCRESAHA.120.317979. Epub 2021 Apr 29.
Genetics of aortic valve disease.
Ackah RL, Yasuhara J, Garg V.
Curr Opin Cardiol. 2023 May 1;38(3):169-178. doi: 10.1097/HCO.0000000000001028. Epub 2023 Jan 30.
AVCAPIR: A Novel Procalcific PIWI-Interacting RNA in Calcific Aortic Valve Disease.
Han D, Zhou T, Li L, Ma Y, Chen S, Yang C, Ma N, Song M, Zhang S, Wu J, Cao F, Wang Y.
Circulation. 2024 May 14;149(20):1578-1597. doi: 10.1161/CIRCULATIONAHA.123.065213. Epub 2024 Jan 23.
Adaptive immune cells in calcific aortic valve disease.
Raddatz MA, Madhur MS, Merryman WD.
Am J Physiol Heart Circ Physiol. 2019 Jul 1;317(1):H141-H155. doi: 10.1152/ajpheart.00100.2019. Epub 2019 May 3.
Calcific Aortic Valve Disease - From Mechanism to Treatment.
Chen Y, Jia S, Zhang J, Han J, Zhang H, Jiang W.
Circ J. 2025 Aug 25;89(9):1447-1452. doi: 10.1253/circj.CJ-24-0706. Epub 2025 May 13.
Treatment strategies for mixed aortic valve disease in nonelderly patients.
Von Stumm M, Petersen J, Westermann D, Reichenspurner H, Girdauskas E.
Expert Rev Cardiovasc Ther. 2019 Dec;17(12):873-882. doi: 10.1080/14779072.2019.1702520. Epub 2019 Dec 13.
Aortic valve disease.
Baxley WA.
Curr Opin Cardiol. 1994 Mar;9(2):152-7. doi: 10.1097/00001573-199403000-00003.
Community burden of aortic valve disease.
Iung B, Arangalage D.
Heart. 2021 Sep;107(18):1446-1447. doi: 10.1136/heartjnl-2021-319560. Epub 2021 Jun 14.
Impact of calcific aortic valve disease on valve mechanics.
Vogl BJ, Niemi NR, Griffiths LG, Alkhouli MA, Hatoum H.
Biomech Model Mechanobiol. 2022 Feb;21(1):55-77. doi: 10.1007/s10237-021-01527-4. Epub 2021 Oct 23.
Calcified Aortic Valve Disease in Patients With Familial Hypercholesterolemia.
Hu H, Cheng J, Lin S, Wang S, Chen X.
J Cardiovasc Pharmacol. 2020 Nov;76(5):506-513. doi: 10.1097/FJC.0000000000000890.
